Group 1: Industry Overview - The Hong Kong Trade Development Council (HKTDC) reports that Hong Kong is collaborating with Guangdong and Macau to advance technological innovation in the Greater Bay Area, with biomedicine emerging as a key industry cluster [1] - The number of biomedical companies in Hong Kong has increased significantly from 2,340 in 2013 to 3,020 in 2023, indicating robust growth in the sector [1] - The Guangdong provincial government aims to accelerate the development of the biomedicine industry, targeting a cluster scale exceeding 1 trillion RMB by 2027, up from 664 billion RMB in 2023, representing a 50% increase [1] Group 2: Financial Landscape - As of June 30, 2025, the total market capitalization of the healthcare sector listed in Hong Kong is $441 billion, accounting for approximately 8.1% of the total market capitalization of listed companies in Hong Kong, a threefold increase from $144 billion at the end of 2017 [2] - There are currently 73 biotech companies listed under the 18A regime, having raised a total of $16 billion [2] - Hong Kong's advanced clinical trial capabilities and internationally recognized clinical trial data position it as an ideal location for expanding global biomedicine businesses [2] Group 3: Startup Ecosystem - The number of biotech and health tech startups in Hong Kong has surged from 110 in 2018 to 510 in 2024, increasing their share of total startups from 4% to 11%, outpacing other startup sectors [3] - These startups are involved in various cutting-edge fields, including new drug development, gene editing technology, medical device innovation, and precision medical solutions [3]

Group 1 - The "Shenzhen-Hong Kong-Guangzhou" innovation cluster ranks first in the 2025 Global Innovation Index, surpassing the "Tokyo-Yokohama" cluster which held the top position for five consecutive years [1] - The "Shenzhen-Hong Kong-Guangzhou" cluster is ranked 45th in innovation intensity, while the "Macau-Zhuhai" cluster, which debuted in 2024, has risen to 98th place and is ranked 81st in innovation intensity [1] - The Greater Bay Area's innovation landscape is characterized by the active collaboration between the Guangzhou-Shenzhen-Hong Kong and Guangzhou-Zhuhai-Macau corridors, with the latter becoming a hub for technology cooperation [1] Group 2 - A number of innovation platforms are emerging along the Guangzhou-Zhuhai-Macau corridor, including the China-Portuguese-speaking Countries Technology Exchange and Cooperation Center in Macau and the Zhuhai-Hengqin Center, both of which are fully operational [2] - The Guangdong-Hong Kong-Macau Greater Bay Area Development Plan emphasizes the construction of an international technology innovation center, aiming to deepen innovation cooperation and create a collaborative innovation community [2] - The plan focuses on gathering international innovation resources, optimizing the innovation policy environment, and enhancing the ability to transform scientific and technological achievements into practical applications [2]